BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15488781)

  • 1. Intrasurgical plasmin enzyme in diabetic macular edema.
    Azzolini C; D'Angelo A; Maestranzi G; Codenotti M; Della Valle P; Prati M; Brancato R
    Am J Ophthalmol; 2004 Oct; 138(4):560-6. PubMed ID: 15488781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.
    Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y
    Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasurgical plasmin enzyme in diabetic macular edema.
    Gandorfer A; Kampik A
    Am J Ophthalmol; 2005 May; 139(5):949; author reply 949-50. PubMed ID: 15860323
    [No Abstract]   [Full Text] [Related]  

  • 4. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous plasmin enzyme in the surgical management of diabetic retinopathy.
    Williams JG; Trese MT; Williams GA; Hartzer MK
    Ophthalmology; 2001 Oct; 108(10):1902-5; discussion 1905-6. PubMed ID: 11581070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery.
    Rizzo S; Pellegrini G; Benocci F; Belting C; Baicchi U; Vispi M
    Retina; 2006 Sep; 26(7):792-6. PubMed ID: 16963853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macular edema caused by contraction of the posterior hyaloid in diabetic retinopathy. Surgical treatment of a series of 22 cases].
    van Effenterre G; Guyot-Argenton C; Guiberteau B; Hany I; Lacotte JL
    J Fr Ophtalmol; 1993; 16(11):602-10. PubMed ID: 8169307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema.
    Diaz-Llopis M; Udaondo P; Arevalo F; Salom D; Garcia-Delpech S; Quijada A; Romero FJ
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):379-84. PubMed ID: 19650710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal tissue plasminogen activator to treat refractory diabetic macular edema by induction of posterior vitreous detachment.
    Abrishami M; Moosavi MN; Shoeibi N; Hosseinpoor SS
    Retina; 2011 Nov; 31(10):2065-70. PubMed ID: 21983248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment.
    Mori K; Saito S; Gehlbach PL; Yoneya S
    Ophthalmology; 2007 Jan; 114(1):127-33. PubMed ID: 17070585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema.
    Gaucher D; Tadayoni R; Erginay A; Haouchine B; Gaudric A; Massin P
    Am J Ophthalmol; 2005 May; 139(5):807-13. PubMed ID: 15860284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tomographic features and surgical outcomes of vitreomacular traction syndrome.
    Yamada N; Kishi S
    Am J Ophthalmol; 2005 Jan; 139(1):112-7. PubMed ID: 15652835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion.
    Udaondo P; Díaz-Llopis M; García-Delpech S; Salom D; Romero FJ
    Arch Ophthalmol; 2011 Mar; 129(3):283-7. PubMed ID: 21402982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.
    Elbendary AM; Elwan MM; Azzam HA; Eldeeb DR
    Curr Eye Res; 2011 Jun; 36(6):534-9. PubMed ID: 21591862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
    Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
    Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitrectomy for diabetic cystoid macular edema -- results of 72 cases].
    Aboutable T; Kalvodova B
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):643-8. PubMed ID: 16118745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.